Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 50, Issue 10

Issues

Global DNA hypomethylation in cancer: review of validated methods and clinical significance

Estela G. Toraño
  • Cancer Epigenetics Laboratory, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), HUCA, Universidad de Oviedo, Oviedo, Spain
  • Estela G. Toraño and Sandra Petrus contributed equally to this review.
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Sandra Petrus
  • Cancer Epigenetics Laboratory, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), HUCA, Universidad de Oviedo, Oviedo, Spain
  • Estela G. Toraño and Sandra Petrus contributed equally to this review.
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Agustin F. Fernandez
  • Cancer Epigenetics Laboratory, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), HUCA, Universidad de Oviedo, Oviedo, Spain
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mario F. Fraga
  • Corresponding author
  • Cancer Epigenetics Laboratory, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), HUCA, Universidad de Oviedo, Oviedo, Spain
  • Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2012-07-15 | DOI: https://doi.org/10.1515/cclm-2011-0902

Abstract

DNA methylation is one of the best-known epigenetic modifications in mammals. The alteration of DNA methylation patterns has been found to be related to many diseases, including cancer. It is well-known that during carcinogenesis, a site-specific DNA hypermethylation and a global DNA hypomethylation take place. This overall loss of DNA methylation has been proposed as a valid biomarker for cancer. Given its medical utility, in recent years it has become apparent that there is a need to develop methods for the analysis of DNA methylation using different approaches: global, locus-specific, or genome-wide. Here we review some of these techniques and discuss their potential clinical utility.

Keywords: biomarkers; cancer; DNA methylation; hypomethylation

About the article

Estela G. Toraño

Estela G. Toraño is a first year PhD student in Cancer Epigenetics under the supervision of Dr. Mario F. Fraga. She has a fellowship from FICYT (Fundación para el fomento en Asturias de la investigación científica aplicada y la tecnología). Before she began her phD, she graduated in Biology and enrolled a master in cancer research at the University of Oviedo. Her work is focused on changes in post-translational modifications of histones during cellular differentiation and tumorigenesis. Also, she works in the study of methylomes of cancer and is familiar with the methods to analyze DNA methylation.

Sandra Petrus

Originally from Menorca (Spain), graduated in Biotechnology and currently Biomedical Sciences master student (Cancer Genomics and Developmental Biology Programme) at the University of Utrecht (The Netherlands). Relevant research experience in genetic epidemiology of bladder cancer, epigenetics in monozygotic twins and developmental biology of blood endothelial cells in zebrafish. Awarded with a Summer-Training fellowship by the Spanish National Cancer Research Centre (CNIO) in 2010 and with a Collaboration grant from the Spanish Ministry of Education and Science (MEC) in 2010–2011.

Agustin F. Fernandez

Agustin F. Fernandez is, at present, a Miguel Servet researcher at the University Institute of Oncology of Asturias (IUOPA) where he works in the Cancer Epigenetics laboratory located at the Asturias Central University Hospital (HUCA), Oviedo, Spain. He received his PhD in Genetics from the University of Oviedo, and worked as postdoctoral fellow in the Laboratory of Cancer Epigenetics at the Spanish National Cancer Research Centre (CNIO), Madrid, Spain, and, later, at the Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain. His main research areas are in the field of epigenetics and comprise the epigenetic mechanisms involved in cell differentiation, and their alterations in aging and different pathologies including cancer.

Mario F. Fraga

Mario F. Fraga is a Tenured Scientist at the National Centre of Biotechnology (CNB-CSIC) and the Head of the Cancer Epigenetics Laboratory at the Institute of Oncology of Asturias (IUOPA), Spain. He received his PhD in plant epigenetics from the University of Oviedo, and was a “Ramon y Cajal” postdoctoral fellow at the Spanish National Cancer Research Centre (CNIO), where he focused his research on cancer epigenetics and the study of human interindividual epigenetic variation. The research interests of his team are epigenetic processes involved in cell differentiation and their alterations in cancer and aging.


Corresponding author: Mario F. Fraga, Centro Nacional de Biotecnología (CNB-CSIC), Darwin, 3 Cantoblanco, 28049 Madrid, Spain Phone: +34 985 109 475


Received: 2011-12-05

Accepted: 2012-06-08

Published Online: 2012-07-15

Published in Print: 2012-10-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 50, Issue 10, Pages 1733–1742, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2011-0902.

Export Citation

©2012 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Tuaeva, Falzone, Porozov, Nosyrev, Trukhan, Kovatsi, Spandidos, Drakoulis, Kalogeraki, Mamoulakis, Tzanakakis, Libra, and Tsatsakis
Cells, 2019, Volume 8, Number 10, Page 1251
[2]
Ruben Daum, Eva M. Brauchle, Daniel Alejandro Carvajal Berrio, Tomasz P. Jurkowski, and Katja Schenke-Layland
Scientific Reports, 2019, Volume 9, Number 1
[3]
Tatiane Moreno Ferrarias Epiphanio, Natália Coelho Couto de Azevedo Fernandes, Tiago Franco de Oliveira, Priscila Assis Lopes, Rodrigo Albergaria Réssio, Simone Gonçalves, Náyra Villar Scattone, Marcello Vannucci Tedardi, Leslie Domenici Kulikowski, Jullian Damasceno, Ana Paula de Melo Loureiro, Maria Lucia Zaidan Dagli, and Y-h. Taguchi
PLOS ONE, 2019, Volume 14, Number 3, Page e0211898
[4]
Yuji Baba, Kaho Yamamoto, and Wataru Yoshida
Analytical and Bioanalytical Chemistry, 2019, Volume 411, Number 19, Page 4765
[5]
[6]
Jirapan Thongsroy, Maturada Patchsung, Monnat Pongpanich, Sirapat Settayanon, and Apiwat Mutirangura
The FASEB Journal, 2018, Volume 32, Number 11, Page 6252
[7]
J. Passador, L. V. Toffoli, K. B. Fernandes, R. D. Neves-Souza, Gislaine Garcia Pelosi, and M. V. Gomes
The journal of nutrition, health & aging, 2018
[8]
Lynn B Bailey, Patrick J Stover, Helene McNulty, Michael F Fenech, Jesse F Gregory, James L Mills, Christine M Pfeiffer, Zia Fazili, Mindy Zhang, Per M Ueland, Anne M Molloy, Marie A Caudill, Barry Shane, Robert J Berry, Regan L Bailey, Dorothy B Hausman, Ramkripa Raghavan, and Daniel J Raiten
The Journal of Nutrition, 2015, Volume 145, Number 7, Page 1636S
[9]
YU SONG and YUN ZUO
Oncology Letters, 2014, Volume 8, Number 5, Page 2340
[10]
Laura Lattanzio
World Journal of Translational Medicine, 2015, Volume 4, Number 1, Page 11
[11]
José Luis García-Giménez, Marta Seco-Cervera, Trygve O. Tollefsbol, Carlos Romá-Mateo, Lorena Peiró-Chova, Pablo Lapunzina, and Federico V. Pallardó
Critical Reviews in Clinical Laboratory Sciences, 2017, Page 1
[12]
Khalid El Bairi, Kanwal Tariq, Imane Himri, Abdeslam Jaafari, Wiam Smaili, Abdul Hafeez Kandhro, Adel Gouri, and Bouchra Ghazi
Cancer Genetics, 2017
[13]
Alberto Ponciano-Gómez, Adolfo Martínez-Tovar, Jorge Vela-Ojeda, Irma Olarte-Carrillo, Federico Centeno-Cruz, and Efraín Garrido
Tumor Biology, 2017, Volume 39, Number 10, Page 101042831773218
[14]
José Luis García-Giménez, Salvador Mena-Mollá, Jesús Beltrán-García, and Fabian Sanchis-Gomar
Clinical Chemistry and Laboratory Medicine (CCLM), 2017, Volume 55, Number 10
[16]
Siliang Wang, Peiliang Shen, Jinrong Zhou, and Yin Lu
Pharmacological Research, 2017, Volume 119, Page 327
[17]
Renjie Wang, Yi Cui, Yi Xu, Joseph Irudayaraj, and Francisco Aguayo
PLOS ONE, 2017, Volume 12, Number 2, Page e0172243
[18]
Sofia Lisanti, Wan A. W. Omar, Bartłomiej Tomaszewski, Sofie De Prins, Griet Jacobs, Gudrun Koppen, John C. Mathers, Sabine A. S. Langie, and Keith William Brown
PLoS ONE, 2013, Volume 8, Number 11, Page e79044
[19]
Chi-Jung Chung, Chao-Hsiang Chang, Saou-Hsing Liou, Chiu-Shong Liu, Huei-Ju Liu, Li-Ching Hsu, Jhih-Sheng Chen, and Hui-Ling Lee
Toxicology and Applied Pharmacology, 2017, Volume 316, Page 107
[20]
Boram Choi, Tae-Su Han, Jimin Min, Keun Hur, Sun-Min Lee, Hyuk-Joon Lee, Young-Joon Kim, and Han-Kwang Yang
Biomarkers, 2017, Volume 22, Number 1, Page 35
[21]
Ole Ammerpohl, Swetlana Scheufele, and Reiner Siebert
medizinische genetik, 2016, Volume 28, Number 2, Page 251
[22]
Wataru Yoshida, Yuji Baba, and Isao Karube
Analytical Chemistry, 2016, Volume 88, Number 18, Page 9264
[23]
Kenan Alkhalili, Georgios Zenonos, and Juan Carlos Fernandez-Miranda
World Neurosurgery, 2016, Volume 92, Page 471
[24]
C. Y. Morimoto, M. V. Tedardi, I. I. M. da Fonseca, K. C. Kimura, D. S. Sanches, T. F. Epiphanio, R. de Francisco Strefezzi, and M. L. Z. Dagli
Veterinary and Comparative Oncology, 2017, Volume 15, Number 3, Page 1014
[25]
Yu Hou, Huahu Guo, Chen Cao, Xianlong Li, Boqiang Hu, Ping Zhu, Xinglong Wu, Lu Wen, Fuchou Tang, Yanyi Huang, and Jirun Peng
Cell Research, 2016, Volume 26, Number 3, Page 304
[26]
Cécile Desjobert, Mounir El Maï, Tom Gérard-Hirne, Dominique Guianvarc'h, Arnaud Carrier, Cyrielle Pottier, Paola B Arimondo, and Joëlle Riond
Epigenetics, 2015, Volume 10, Number 1, Page 82
[27]
Kathryn Hughes Barry, Lee E. Moore, Linda M. Liao, Wen-Yi Huang, Gabriella Andreotti, Matthew Poulin, and Sonja I. Berndt
The Prostate, 2015, Volume 75, Number 15, Page 1718
[28]
Xingyu Si, Yaoyao Zhao, Chengdui Yang, Sichun Zhang, and Xinrong Zhang
Scientific Reports, 2015, Volume 5, Number 1
[29]
Yu Wang, Wei Wu, Chunji Yao, Jianlin Lou, Riping Chen, Lingzhi Jin, Nanxiang Wu, Ming Gao, Peng Song, Yufeng Tan, and Kecheng Liu
Environmental Toxicology, 2016, Volume 31, Number 9, Page 1080
[31]
Katriina Huumonen, Merja Korkalainen, Matti Viluksela, Tapani Lahtinen, Jonne Naarala, and Jukka Juutilainen
Frontiers in Public Health, 2014, Volume 2
[32]
Luciane Tsukamoto Kagohara, Juliana L Schussel, Tejaswini Subbannayya, Nandini Sahasrabuddhe, Cynthia Lebron, Mariana Brait, Leonel Maldonado, Blanca L. Valle, Francesca Pirini, Martha Jahuira, Jaime Lopez, Pablo Letelier, Priscilla Brebi-Mieville, Carmen Ili, Akhilesh Pandey, Aditi Chatterjee, David Sidransky, and Rafael Guerrero-Preston
Future Oncology, 2015, Volume 11, Number 2, Page 233
[33]
Katarzyna M. Marcinkiewicz and Lorraine J. Gudas
Journal of Cellular Physiology, 2014, Volume 229, Number 10, Page 1405
[34]
Wen Li and Bi-feng Chen
Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, Volume 33, Number 6, Page 798
[35]
Søren Kristiansen, Dorte Nielsen, and György Sölétormos
Critical Reviews in Clinical Laboratory Sciences, 2014, Volume 51, Number 3, Page 149
[36]
Doria Filipponi, Julius Muller, Alexander Emelyanov, and Dmitry V. Bulavin
Cancer Cell, 2013, Volume 24, Number 4, Page 528
[37]
Edurne San Jose-Eneriz, Xabier Agirre, Paula Rodríguez-Otero, and Felipe Prosper
Epigenomics, 2013, Volume 5, Number 5, Page 525
[38]
Diego M. Marzese, Richard A. Scolyer, Jamie L. Huynh, Sharon K. Huang, Hajime Hirose, Kelly K. Chong, Eiji Kiyohara, Jinhua Wang, Neal P. Kawas, Nicholas C. Donovan, Keisuke Hata, James S. Wilmott, Rajmohan Murali, Michael E. Buckland, Brindha Shivalingam, John F. Thompson, Donald L. Morton, Daniel F. Kelly, and Dave S.B. Hoon
Human Molecular Genetics, 2014, Volume 23, Number 1, Page 226
[39]
Kamalika Saha, Thomas J. Hornyak, and Richard L. Eckert
The AAPS Journal, 2013, Volume 15, Number 4, Page 1064
[40]
Jason Brocato and Max Costa
Critical Reviews in Toxicology, 2013, Volume 43, Number 6, Page 493
[41]
Yukun Zhang, Qian Li, and Hong Chen
Carcinogenesis, 2013, Volume 34, Number 8, Page 1756

Comments (0)

Please log in or register to comment.
Log in